Identification and Optimization of a Minor Allele-Specific siRNA to Prevent PNPLA3 I148M-Driven Nonalcoholic Fatty Liver Disease

Author:

Murray Justin K.1,Long Jason1,Liu Lei2,Singh Shivani2,Pruitt Danielle2,Ollmann Michael3,Swearingen Elissa3,Hardy Miki3,Homann Oliver3,Wu Bin1,Holder Jerry Ryan1,Sham Kelvin1,Herberich Brad1,Lo Mei-Chu4,Dou Hui4,Shkumatov Artem5,Florio Monica6,Rulifson Ingrid C.2ORCID

Affiliation:

1. Therapeutic Discovery, Amgen Research, Thousand Oaks, California, USA.

2. Cardiometabolic Disorders, Amgen Research, South San Francisco, California, USA.

3. Genome Analysis Unit, Amgen Research, South San Francisco, California, USA.

4. Therapeutic Discovery, Amgen Research, South San Francisco, California, USA.

5. Translational Safety and Bioanalytical Sciences, Amgen Research, South San Francisco, California, USA.

6. Cardiometabolic Disorders, Amgen Research, Thousand Oaks, California, USA.

Publisher

Mary Ann Liebert Inc

Subject

Drug Discovery,Genetics,Molecular Biology,Molecular Medicine,Biochemistry

Cited by 12 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3